Enjoy complimentary customisation on priority with our Enterprise License!
The single-use bioprocessing system market size is forecast to increase by USD 15.32 billion at a CAGR of 19.38% between 2023 and 2028. The market is experiencing significant growth due to the high demand for biopharmaceuticals to treat various diseases. The upstream bioprocessing segment, which involves the production of raw materials and cells, is a key driver for the market. Downstream bioprocessing, which involves the purification and formulation of the final product, is also witnessing advancements and automation, leading to increased efficiency and productivity. However, validation issues while selecting suppliers and integrators pose a challenge to the market. Ensuring the quality and reliability of these systems is crucial to maintain regulatory compliance and ensure patient safety. Overall, the market is expected to continue its growth trajectory, driven by technological advancements and the increasing demand for biopharmaceuticals.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Market Segmentation by End-user
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Trends
12 Vendor Landscape
13 Vendor Analysis
14 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.